Contact Information
815 Rowena Drive , Ebensburg, Pennsylvania 15931, United States
Detailed Information
Impact Counseling Service
-
Services:
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- TB screening
- Drug or alcohol urine screening
- No formal relationship with prescribing entity
- Screening for tobacco use
- Screening for substance use
- Complete medical history/physical exam
- Comprehensive substance use assessment
- Outreach to persons in the community
- Cash or self-payment
- Federal, or any government funding for substance use treatment programs
- Federal military insurance (e.g., TRICARE)
- State-financed health insurance plan other than Medicaid
- Private health insurance
- Medicaid
- Clients who have experienced trauma
- Adolescents
- Clients with co-occurring pain and substance use disorders
- Clients with co-occurring mental and substance use disorders
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- No formal relationship with prescribing entity
- Vaping permitted in designated area
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Group counseling
- Substance use disorder education
- HIV or AIDS education, counseling, or support
- Marital/couples counseling
- Hepatitis education, counseling, or support
- Family counseling
- Individual counseling
- Cognitive behavioral therapy
- Telemedicine/telehealth therapy
- Brief intervention
- Motivational interviewing
- 12-step facilitation
- Relapse prevention
- Substance use disorder counseling
- Anger management
- Trauma-related counseling
- Aftercare/continuing care
- Naloxone and overdose education
- Outcome follow-up after discharge
- Discharge Planning
- Private for-profit organization
- Prescribes naltrexone
- Prescribes buprenorphine
- Maintenance service with medically supervised withdrawal after stabilization
- Accepts clients using MAT but prescribed elsewhere
- Buprenorphine sub-dermal implant
- Naltrexone (extended-release, injectable)
- Buprenorphine (extended-release, injectable)
- Buprenorphine with naloxone
- Buprenorphine without naloxone
- Substance use treatment
- Smoking permitted in designated area
- Male
- Female
- Housing services
- Assistance with obtaining social services
- Treatment for other addiction disorder
- SAMHSA certification for opioid treatment program (OTP)
- State Substance use treatment agency
Opioid Medications used in Treatment
Testing
External Opioid Medications Source
Assessment/Pre-treatment
Payment/Insurance/Funding Accepted
Special Programs/Groups Offered
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
External Source of Medications Used for Alcohol Use Disorder Treatment
Facility Vaping Policy
Type of Alcohol Use Disorder Treatment
Education and Counseling Services
Treatment Approaches
Transitional Services
Facility Operation (e.g., Private, Public)
Type of Opioid Treatment
Pharmacotherapies
Type of Care
Facility Smoking Policy
Gender Accepted
Recovery Support Services
Other Services
License/Certification/Accreditation
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm